
JAK/STAT pathway mutations cause myeloproliferative neoplasms and often exhibit additional mutations targeting other pathways. These diseases have a chronic phase followed by an accelerated phase or transformation into more aggressive diseases. Recent studies have shed light on the rates and mechanisms of mutation acquisition and selection in hematopoietic cells. Techniques at the single-cell level can help decipher the clonal architecture and the impact of clonal evolution on clinical evolution. This review summarizes the latest research on these topics.
Like
Save
Share